Speaker Profile
Biography
Dr. Odegaard is currently the Vice President of Clinical Development and Product at Guardant Health, Inc., a diagnostics company focused on building tools to improve the care of cancer patients. He earned MD and PhD degrees from Stanford University, where he trained in surgical and molecular pathology. Prior to Guardant Health, he worked at Lifecode, Inc. as Director of Molecular Biology, OneOme Laboratories as Laboratory Director, Stanford University on the adjunct faculty, and at the University of California San Francisco as an Assistant Professional Researcher.
Talk
Accelerating Drug Development Through Epigenomic Diagnostics
Clinical Dx Showcase:
Guardant Health
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative